The article from the New England Journal of Medicine from September 2026 addresses the clinical use of common genetic variants associated with widespread diseases. Genetic variants represent small changes in DNA sequences that occur in a large proportion of the population. These variants can influence the risk of developing various diseases including cardiovascular disease, diabetes, and other health conditions. Understanding these genetic factors enables better prediction of disease risk in individual patients. Clinical applications include personalized medicine and adaptation of treatment strategies based on the patient's genetic profile. This approach can improve treatment efficacy and reduce the occurrence of adverse effects.